Group 1 (n = 138) | Group 2 (n = 137) | P | Group 1 (n = 100) | Group 2 (n = 100) | P | |
---|---|---|---|---|---|---|
Demographics | ||||||
Age (years) | 56.1 ± 7.8 | 55.2 ± 7.1 | 0.34 | 56 ± 7.2 | 55.3 ± 7 | 0.48 |
Male | 119 (86.2%) | 113 (82.5%) | 0.39 | 85 (85%) | 81 (81%) | 0.58 |
BMI (kg/m2) | 30.9 (27.8–35.9%) | 31.1 (27.7–33.6) | 0.18 | 30.4 (28.4–36.4) | 31.6 (27.7–34.1) | 0.53 |
BSA (m2) | 2.03 (1.9–2.1) | 1.96 (1.89–2.05) | 0.07 | 2.03 (1.93–2.1) | 1.97 (1.89–2.01) | 0.15 |
Comorbidities | ||||||
DM | 75 (54.4%) | 65 (47.8%) | 0.28 | 54 (54%) | 47 (47%) | 0.36 |
Hypercholesteremia | 61 (46.2%) | 56 (41.5%) | 0.44 | 44 (44%) | 40 (40%) | 0.46 |
Hypertension | 87 (63%) | 86 (63.2%) | 0.97 | 63 (63%) | 61 (61%) | 0.87 |
Hypothyroidism | 3 (2.2%) | 1 (0.8%) | 0.62 | 2 (2%) | 0 | 0.5 |
Renal impairment | 3 (2.2%) | 1 (0.8%) | 0.62 | 0 | 1 (1%) | > 0.99 |
Respiratory disease | 1 (0.7%) | 4 (2.96%) | 0.21 | 1 (1%) | 2 (2%) | > 0.99 |
CVD | 2 (1.5%) | 2 (1.5%) | > 0.99 | 1 (1%) | 2 (2%) | > 0.99 |
PVD | 3 (2.3%) | 4 (3%) | > 0.99 | 3 (3%) | 2 (2%) | > 0.99 |
HF (within 1 year) | 3 (2.2%) | 8 (6%) | 0.13 | 3 (3%) | 1 (1%) | 0.63 |
Previous MI | 0.93 | 0.39 | ||||
1 attack | 41 (30.2%) | 39 (29.55%) | 27 (27%) | 31 (31%) | ||
2 or more | 12 (8.8%) | 10 (7.6%) | 10 (10%) | 5 (5%) | ||
Previous PCI | 11 (8%) | 12 (8.8%) | 0.81 | 9 (9%) | (9%) | > 0.99 |
Symptoms | ||||||
Angina class | < 0.001 | 0.35 | ||||
I | 0 | 2 (1.4%) | 0 | 0 | ||
II | 14 (10.4%) | 35 (25.9%) | 14 (14%) | 13 (13%) | ||
III | 122 (88.4%) | 86 (63.7%) | 85 (85%) | 81 (81%) | ||
IV | 2 (1.5%) | 12 (8.9%) | 1 (1%) | 6 (6%) | ||
NYHA (III/IV) | 120 (87%) | 85 (62%) | < 0.001 | 84 (84%) | 75 (75%) | 0.15 |
Investigations: | ||||||
Creatinine (mg/dl) | 1 (0.8–1.2) | 0.9 (0.8–1.2) | 0.38 | 1 (0.8–1.1) | 0.9 (0.8–1.19) | 0.89 |
Bilirubin (mg/dl) | 0.6 (0.4–0.7) | 0.6 (0.4–0.9) | 0.28 | 0.6 (0.4–0.9) | 0.7 (0.4–0.9) | 0.12 |
EF | > 0.99 | > 0.99 | ||||
Good (> 50%) | 100 (73.5%) | 99 (73.9%) | 73 (73%) | 74 (74%) | ||
Fair (30–50%) | 35 (25.7%) | 34 (25.4%) | 24 (24%) | 23 (23%) | ||
Poor (< 30%) | 1 (0.7%) | 1 (0.8%) | 1 (1%) | 1 (1%) | ||
IV nitrates | 2 (1.5%) | 1 (0.8%) | > 0.99 | 1 (1%) | 1 (1%) | > 0.99 |